Jiangxi Institute of Biological Products FY26 H1 profit drops 60.99% to RMB 14.37 million; revenue falls 16.5% to RMB 83.29 millionPUBT·1 day ago, 09:18 AM06915+2.53%
Weekly Recap | JIANGXI BIO +13.89%, consensus target above spotWeekly Review·Aug 29 at 04:55 AM06915+2.53%
Hong Kong stock movement: JIANGXI BIO rises 15.23% with no major positive news? Active funds drive fluctuationsHK Stock Alerts·Aug 27 at 06:31 AM06915+2.53%
Hong Kong Stock Movement: JIANGXI BIO falls 15.19%: Under pressure on the first day of dark market trading below issue price, concerns arise from high valuation and fundamental worriesHK Stock Alerts·Aug 26 at 07:56 AM06915+2.53%
Weekly Recap | JIANGXI BIO +10.57%, new coverage flags antiserum platform pivotWeekly Review·Aug 22 at 04:22 AM06915+2.53%
Hong Kong stock movement: JIANGXI BIO surged 21%, China Merchants Securities initiated a buy rating, transforming into an anti-serum platformHK Stock Alerts·Aug 20 at 02:48 AM06915+2.53%
Hong Kong stock movement: JIANGXI BIO rises 17.86%, with interim performance disclosure imminent, funds pouring in to boost stock priceHK Stock Alerts·Aug 20 at 02:18 AM06915+2.53%
Jiangxi Institute of Biological Products schedules board meeting to release interim resultsPUBT·Aug 17 at 08:34 AM06915+2.53%
Hong Kong Stock Movement: JIANGXI BIO rises 15.39% as funds pour in; is the sector trend-driven or valuation risk?HK Stock Alerts·Aug 12 at 06:03 AM06915+2.53%
Hong Kong Stock Movement: JIANGXI BIO surged 22.39%, with active capital and sector trends driving volatilityHK Stock Alerts·Aug 11 at 05:22 AM06915+2.53%
